Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for DBV Technologies S.A. (DBVT)

« Back to company index

DBVT Chatter Timeline

Stock Ticker for DBVT

Most Active Tweeters for DBVT

UserTweets
@whatsonthorold2 3
@mmahotstuff1 3
@bibeypost_stock 3
@ConsumerFeed 2
@reurope_stock 2

Recent Tweets for DBVT

WatchlistN @WatchlistN
DBV Technologies $DBVT Upgraded to Hold by Zacks Investment Research https://t.co/Bdbe12bLxc
July 18th 2018, 12:07pm
TickerReport @TickerReport
DBV Technologies $DBVT Upgraded to Hold by Zacks Investment Research https://t.co/jpqO5gochE
July 18th 2018, 12:07pm
MareaInformativ @MareaInformativ
DBV Technologies $DBVT Upgraded to “Hold” by Zacks Investment Research https://t.co/QgusplyhWe
July 17th 2018, 10:07pm
ConsumerFeed @ConsumerFeed
DBV Technologies $DBVT Hits New 12-Month Low at $18.17 https://t.co/QS7lzbfV9Z
July 17th 2018, 4:07pm
BehaviorFin @BehaviorFin
RT @BiotechRadar: ?Hard times for ?? $DBV $DBVT, leaving the French biotech lead to Cellectis another time this year market-cap-wise. Despi…
July 17th 2018, 3:07pm
BiotechRadar @BiotechRadar
?Hard times for ?? $DBV $DBVT, leaving the French biotech lead to Cellectis another time this year market-cap-wise.… https://t.co/kVgV1RrFse
July 17th 2018, 3:07pm
BiotechRadar @BiotechRadar
$DBV Technologies $DBVT pipeline & milestones (June) - still waiting for Viaskin Peanut BLA filing... https://t.co/As5rq4XM1s
July 17th 2018, 12:07pm
bibeypost_stock @bibeypost_stock
Does DBV Technologies S.A. $DBVT Have Any Gas After Making 52-Week Low? - https://t.co/IAycA557Sg
July 17th 2018, 12:07pm
reurope_stock @reurope_stock
After Reaching 52 Week Low, Is DBV Technologies S.A. $DBVT's Near-Term Analysis Negative? https://t.co/CsRv57NJ5F
July 17th 2018, 12:07pm
mmahotstuff1 @mmahotstuff1
DBV Technologies S.A. $DBVT Just Reaches 1 Year Low? - https://t.co/DsriCL9si8
July 17th 2018, 12:07pm
whatsonthorold2 @whatsonthorold2
DBV Technologies S.A. $DBVT's Trend Down, Especially After Today's 52 Week Low Hit - https://t.co/tQUF0nTsf1
July 17th 2018, 12:07pm
bibeypost_stock @bibeypost_stock
Were Analysts Bearish DBV Technologies S.A. $DBVT This Week? - https://t.co/rTZgIsJ9TY
July 17th 2018, 9:07am
reurope_stock @reurope_stock
DBV Technologies S.A. $DBVT has analysts on the Bullish side this week. https://t.co/n0D6Rl9wFQ
July 17th 2018, 9:07am
mmahotstuff1 @mmahotstuff1
Is there a Bearish outlook for DBV Technologies S.A. $DBVT this week? - https://t.co/jCHytq7xSM
July 17th 2018, 9:07am
whatsonthorold2 @whatsonthorold2
Are Analysts Bullish DBV Technologies S.A. $DBVT After Last Week? - https://t.co/VvnvJIMI0Q
July 17th 2018, 9:07am
OlympiaReport @OlympiaReport
DBV Technologies $DBVT Price Target Raised to $28.00 at Morgan Stanley https://t.co/c11xvOg6GV
July 17th 2018, 3:07am
dispatchtribune @dispatchtribune
DBV Technologies $DBVT Price Target Raised to $28.00 at Morgan Stanley https://t.co/rdnxAgRkHW
July 17th 2018, 3:07am
ThisLincolnian @ThisLincolnian
DBV Technologies $DBVT Price Target Increased to $28.00 by Analysts at Morgan Stanley https://t.co/R1z21Tn1TK
July 16th 2018, 10:07am
ConsumerFeed @ConsumerFeed
DBV Technologies $DBVT Given New $28.00 Price Target at Morgan Stanley https://t.co/SNhpeB33Yc
July 15th 2018, 9:07am
StockTipRobot @StockTipRobot
DANGER Will Robinson!! Just kidding. Go stop buying DBV Technologies S.A. $DBVT #StockAdvice
July 15th 2018, 3:07am
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $DBVT for you: -7.05% https://t.co/DZKfD6SzyQ
July 14th 2018, 6:07pm
hkbbcatt @hkbbcatt
RT @tgtxdough: $DBVT Key Value Drivers Full data presentation from PhIII safety/efficacy PEPITES study of Viaskin Peanut Regulatory feedbac…
July 14th 2018, 5:07pm
tgtxdough @tgtxdough
$DBVT Key Value Drivers Full data presentation from PhIII safety/efficacy PEPITES study of Viaskin Peanut Regulator… https://t.co/AptqQe7PXo
July 14th 2018, 5:07pm
teebizy @teebizy
RT @DrSManian: $DBVT MC <500M Monster gap to fill Prominent Tute stakes ?Baker? Flynn? Edelman https://t.co/5eNBCQnRsy
July 13th 2018, 11:07pm
DrSManian @DrSManian
$DBVT MC <500M Monster gap to fill Prominent Tute stakes ?Baker? Flynn? Edelman https://t.co/5eNBCQnRsy
July 13th 2018, 11:07pm
bibeypost_stock @bibeypost_stock
DBV Technologies $DBVT: Morgan Stanley Maintains "Equal-Weight" Rating Today, Has a Target of $28/Share - https://t.co/x1kJxhKwJp
July 13th 2018, 9:07am
mmahotstuff1 @mmahotstuff1
Breaking: Morgan Stanley Maintains $28 Target Price per Share On DBV Technologies $DBVT Shares, Maintains Their Ori… https://t.co/B6nz0qVRkc
July 13th 2018, 8:07am
whatsonthorold2 @whatsonthorold2
Morgan Stanley Kept DBV Technologies $DBVT As a Equal-Weight; They Now Have a TP Of $28 - https://t.co/bIc6kA8BIr
July 13th 2018, 8:07am
hotpennyalerts @hotpennyalerts
$DBVT Issues Half-Year Report on its liquidity contract with Natixis https://t.co/gVkzbiukJB
July 13th 2018, 6:07am
ThisLincolnian @ThisLincolnian
Head-To-Head Comparison: La Jolla Pharmaceutical $LJPC vs. DBV Technologies $DBVT https://t.co/UX2Jxex8V8
July 8th 2018, 10:07am
SwingTradeBot @SwingTradeBot
Recent $DBVT technical alerts: MACD Bullish Signal Line Cross plus 3 more alerts... https://t.co/jBMxhHFfB3
July 7th 2018, 3:07pm
1MinuteStock @1MinuteStock
Wondering about risks of $DBVT? The 63-day volatility is 15.08% https://t.co/bSXXNqW6KL
July 7th 2018, 3:07pm
WatchlistN @WatchlistN
Head to Head Survey: DBV Technologies $DBVT versus La Jolla Pharmaceutical $LJPC https://t.co/zEShgg2Iy1
July 4th 2018, 2:07am
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $DBVT for you: -13.98% https://t.co/DZKfD6SzyQ
July 2nd 2018, 7:07am
registrarjourn @registrarjourn
DBV Technologies $DBVT Receives Consensus Rating of “Hold” from Brokerages https://t.co/kGxXlQkgRk
July 1st 2018, 3:07pm
SwingTradeBot @SwingTradeBot
Recent $DBVT technical alerts: Lower Bollinger Band Walk plus 11 more alerts... https://t.co/jBMxhHFfB3
July 1st 2018, 9:07am
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $DBVT? The Short Ratio is 0.79% https://t.co/BUYXXmYd61
June 30th 2018, 3:06pm
1MinuteStock @1MinuteStock
Wondering about risks of $DBVT? The 21-day volatility is 8.25% https://t.co/bSXXNqW6KL
June 30th 2018, 2:06pm
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $DBVT https://t.co/bv72KxUxaH
June 30th 2018, 1:06pm
SwingTradeBot @SwingTradeBot
Recent $DBVT technical alerts: Lower Bollinger Band Walk plus 12 more alerts... https://t.co/jBMxhHFfB3
June 30th 2018, 11:06am
TickerReport @TickerReport
DBV Technologies $DBVT Receives $44.00 Average Target Price from Analysts https://t.co/qpRu91gCsD
June 29th 2018, 11:06pm
MareaInformativ @MareaInformativ
Oak Ridge Investments LLC Decreases Position in DBV Technologies $DBVT https://t.co/lfGH1uuiw2
June 29th 2018, 11:06pm
normanobserver @normanobserver
DBV Technologies S.A. $DBVT Reaches $19.18 After 5.00% Up Move; Blair William & Company Boosted Dynavax Technologie… https://t.co/nl2YvvbQ8C
June 29th 2018, 12:06pm
EnterpriseLeade @EnterpriseLeade
DBV Technologies $DBVT Given Average Recommendation of “Hold” by Analysts https://t.co/DbrGyBCUf7
June 29th 2018, 4:06am
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $DBVT? The Short Ratio is 9.06% https://t.co/BUYXXmYd61
June 29th 2018, 1:06am
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $DBVT is $0 it's 0% of the current price https://t.co/D9OPULYjxb
June 29th 2018, 12:06am
EnterpriseLeade @EnterpriseLeade
BidaskClub Lowers DBV Technologies $DBVT to Strong Sell https://t.co/t7KziW47Id
June 28th 2018, 6:06pm
ConsumerFeed @ConsumerFeed
DBV Technologies $DBVT Sets New 12-Month Low at $19.00 https://t.co/JoMcNiAhKZ
June 28th 2018, 5:06am
fintel_io @fintel_io
Baker Brothers Advisors LP has filed an amended 13D/A, reporting 16.0% ownership in $DBVT - https://t.co/YPxDj2Snii
June 26th 2018, 7:06pm
whalewisdom @whalewisdom
New SC 13D/A from BAKER BROS. ADVISORS LP concerning $DBVT. See details at https://t.co/2DjbCFem7g
June 26th 2018, 5:06pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.